294 related articles for article (PubMed ID: 32881078)
1. Efficacy of low dose rectal diclofenac for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: Propensity score-matched analysis.
Tomoda T; Kato H; Miyamoto K; Matsumi A; Ueta E; Fujii Y; Saragai Y; Yamazaki T; Uchida D; Matsumoto K; Horiguchi S; Tsutsumi K; Okada H
Dig Endosc; 2021 May; 33(4):656-662. PubMed ID: 32881078
[TBL] [Abstract][Full Text] [Related]
2. Rectal administration of low-dose diclofenac does not reduce post-endoscopic retrograde cholangiopancreatography pancreatitis: a propensity score matching analysis.
Sakai H; Iwai N; Sakagami J; Okuda T; Ohara T; Hattori C; Taniguchi M; Oka K; Hara T; Tsuji T; Komaki T; Kagawa K; Dohi O; Yasuda H; Konishi H; Itoh Y
Surg Endosc; 2023 Apr; 37(4):2698-2705. PubMed ID: 36443561
[TBL] [Abstract][Full Text] [Related]
3. The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Okuno M; Shiroko J; Taguchi D; Yamaguchi K; Takada J; Imai S; Sato H; Thanabashi S
Intern Med; 2018 Aug; 57(16):2289-2294. PubMed ID: 29607957
[TBL] [Abstract][Full Text] [Related]
4. Rectally Administered Low-Dose Diclofenac Has No Effect on Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Propensity Score Analysis.
Takaori A; Ikeura T; Hori Y; Ito T; Nakamaru K; Masuda M; Mitsuyama T; Miyoshi H; Shimatani M; Takaoka M; Okazaki K; Naganuma M
Pancreas; 2021 Aug; 50(7):1024-1029. PubMed ID: 34629455
[TBL] [Abstract][Full Text] [Related]
5. Low-dose rectal diclofenac does not prevent post-ERCP pancreatitis in low- or high-risk patients.
Katoh T; Kawashima K; Fukuba N; Masuda S; Kobatake H; Masaki K; Araki Y; Kawano K; Nishi K; Takenaka M; Ishihara S; Kinoshita Y
J Gastroenterol Hepatol; 2020 Jul; 35(7):1247-1253. PubMed ID: 31788849
[TBL] [Abstract][Full Text] [Related]
6. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
7. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of high-dose rectal diclofenac suppository and epinephrine spray on duodenal papilla for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Dar HA; Shah A; Javid G; Khan MA; Singh B; Sheikh NA; Ashraf A; Mohammad S
Indian J Gastroenterol; 2021 Oct; 40(5):483-491. PubMed ID: 34767149
[TBL] [Abstract][Full Text] [Related]
9. Rectal Nonsteroidal Anti-Inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: A Network Meta-Analysis.
Yang J; Wang W; Liu C; Zhao Y; Ren M; He S
J Clin Gastroenterol; 2020 Apr; 54(4):305-313. PubMed ID: 32011404
[TBL] [Abstract][Full Text] [Related]
10. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
[TBL] [Abstract][Full Text] [Related]
11. Can Rectal Diclofenac Prevent Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis?
Lua GW; Muthukaruppan R; Menon J
Dig Dis Sci; 2015 Oct; 60(10):3118-23. PubMed ID: 25757446
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
[TBL] [Abstract][Full Text] [Related]
13. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial.
Otsuka T; Kawazoe S; Nakashita S; Kamachi S; Oeda S; Sumida C; Akiyama T; Ario K; Fujimoto M; Tabuchi M; Noda T
J Gastroenterol; 2012 Aug; 47(8):912-7. PubMed ID: 22350703
[TBL] [Abstract][Full Text] [Related]
14. Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study.
Geraci G; Palumbo VD; D'Orazio B; Maffongelli A; Fazzotta S; Lo Monte AI
Clin Ter; 2019; 170(5):e332-e336. PubMed ID: 31612188
[TBL] [Abstract][Full Text] [Related]
15. Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography.
Tomoda T; Kato H; Ueki T; Akimoto Y; Hata H; Fujii M; Harada R; Ogawa T; Wato M; Takatani M; Matsubara M; Kawai Y; Okada H
Gastroenterology; 2019 May; 156(6):1753-1760.e1. PubMed ID: 30772342
[TBL] [Abstract][Full Text] [Related]
16. The Incidence and Severity of Post-ERCP Pancreatitis in Patients Receiving Standard Administration of NSAIDs: a Systematic Review and Meta-analysis.
Kang X; Guo X; Chen Z; Zhou Z; Luo H; Lu Y; Lou L; Guo X; Pan Y
J Gastrointest Surg; 2022 Nov; 26(11):2380-2389. PubMed ID: 35941494
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
[TBL] [Abstract][Full Text] [Related]
18. Universal prophylactic rectal nonsteroidal anti-inflammatory drugs with a policy of selective pancreatic duct stenting significantly reduce post-endoscopic retrograde cholangiopancreatography pancreatitis.
Agarwal A; Mahapatra SJ; Sethia R; Agarwal S; Elhence A; Mohta S; Gunjan D; Garg PK
Indian J Gastroenterol; 2023 Jun; 42(3):370-378. PubMed ID: 37160838
[TBL] [Abstract][Full Text] [Related]
19. Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta-analysis.
Shen C; Shi Y; Liang T; Su P
Dig Endosc; 2017 May; 29(3):281-290. PubMed ID: 28112441
[TBL] [Abstract][Full Text] [Related]
20. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-analysis.
Rustagi T; Njei B
Pancreas; 2015 Aug; 44(6):859-67. PubMed ID: 26168316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
